期刊
DIAGNOSTICS
卷 11, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/diagnostics11112090
关键词
atopic dermatitis; biologic agents; neuroimmune interactions; type 2 inflammation
资金
- Foundation of Strategic Research Projects in Private Universities [S1311011]
- JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [18K07396, 20H03568]
- Lydia O'Leary Memorial Pias Dermatological Foundation
- Grants-in-Aid for Scientific Research [20H03568, 18K07396] Funding Source: KAKEN
Recent evidence on type 2 inflammation-associated itch in atopic dermatitis has been reported, highlighting the importance of neuroimmune interactions in research. Understanding bidirectional neuroimmune interactions is crucial in gaining insights into the pathogenesis of itch and its treatment. Improved management and treatment options for itch in atopic dermatitis are being explored through novel and targeted biologic agents in advanced clinical trials.
Accumulated evidence on type 2 inflammation-associated itch in atopic dermatitis has recently been reported. Crosstalk between the immune and nervous systems (neuroimmune interactions) is prominent in atopic dermatitis research, particularly regarding itch and inflammation. A comprehensive understanding of bidirectional neuroimmune interactions will provide insights into the pathogenesis of itch and its treatment. There is currently no agreed cure for itch in atopic dermatitis; however, increasing numbers of novel and targeted biologic agents have potential for its management and are in the advanced stages of clinical trials. In this review, we summarize and discuss advances in our understanding of type 2 inflammation-associated itch and implications for its management and treatment in patients with atopic dermatitis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据